People In Brief
This article was originally published in The Gray Sheet
MicroMed Cardiovascular CEO
You may also be interested in...
Thermo Fisher Scientific wants to claim a dominant share of the budding in vitro allergy testing market segment in the U.S. with its planned $3.5 billion acquisition of Swedish firm Phadia, announced May 19.
PCORI executive director
Medingo nabs Medtronic alum: Israeli insulin-dispensing patch pump maker appoints former Medtronic VP Pete Wehrly as president and CEO, effective Nov. 2. Wehrly, who previously ran Medtronic's spinal and biologics business and its Sofamor Danek orthopedic unit, replaces company founder Ofer Yodfat, who will remain on as general manager. The appointment coincides with Medingo's establishment of U.S.-based operations